- Home
- BANR vs IMNM Comparison
BANR vs IMNM Comparison
Compare BANR & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | IMNM |
|---|---|---|
| Founded | 1890 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BANR | IMNM |
|---|---|---|
| Price | $66.24 | $19.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $71.20 | $26.89 |
| AVG Volume (30 Days) | 167.7K | ★ 1.1M |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $640,027,000.00 | $9,679,000.00 |
| Revenue This Year | $0.69 | N/A |
| Revenue Next Year | $9.90 | N/A |
| P/E Ratio | $12.08 | ★ N/A |
| Revenue Growth | ★ 7.86 | N/A |
| 52 Week Low | $54.01 | $5.15 |
| 52 Week High | $74.06 | $20.80 |
Technical Indicators
Market Signals| Indicator | BANR | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 58.69 |
| Support Level | $64.18 | $18.87 |
| Resistance Level | $67.53 | $20.80 |
| Average True Range (ATR) | 1.35 | 1.22 |
| MACD | 0.39 | -0.02 |
| Stochastic Oscillator | 80.05 | 70.80 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.